In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines

Cancer Letters

Volumn 139, Issue 1, 1999, Pages 67-73

  Verhaar, Marlies J ^a   Damen, Cora A ^a   Zonnenberg, Bernard A ^a   Blijham, Geert H ^a  

^a Dept Int Med Univ Hosp U ^*  (Netherlands)

Author keywords

bFGF; Carcinoembryonic antigen; Interferon; Interleukin 6; Tumours

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; PRIORITY JOURNAL; PROTEIN TARGETING;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; TIME FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032899261     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00007-5     Document Type: Article

References (18)

1. Atallah A.M., Needy C.F., Noguchi P.D., et al. Enhancement of carcinoembryonic antigen expression by interferon. Int. J. Cancer. 24:1979;49-52.
2. Begent R.H.J. Targeted therapies: cell surface targets. Ponder B. Cancer Biology and Medicine. 2:1990;161-184 Kluwer Academic Publications.
3. Begent R.H.J., Verhaar M.J., Chester K.A., et al. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med. 2(9):1996;979-984.
4. Borden E.C. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma. Semin. Oncol. 21:1994;14-22.
5. Chester K.A., Begent R.H.J., Robson L., et al. Phage libraries for generation of clinically useful antibodies. Lancet. 343:1994;455-456.
6. Dansky Ullmann C., Schlomm J., Greiner J.W. Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells. J. Immunother. 12:1992;231-241.
7. Dansky Ullmann C., Salgaller M., Adams S., et al. Synergistic effects of Il-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA-expression by human colorectal carcinoma cells; role for endogenous IFN-beta. Cytokine. 7(2):1995;118-129.
8. Folkmann J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
9. Greiner J.W., Tobi M., Fisher P.B., et al. Differential responsiveness of cloned mammary carcinoma cell populations to human recombinant leucocyte alpha interferon mediated enhancement of human antigen expression. Int. J. Cancer. 36:1985;159-166.
10. Greiner J.W., Guadagni F., Horan Hand P., et al. Augmentation of tumor antigen expression by recombinant human IFN's: enhanced targeting of monoclonal antibodies to carcinomas. Goldenberg D.M., et al. Cancer Imaging with Radiolabelled Antibodies. 1990;413-432 Norwell MA, Nijhoff.
11. Greiner J.W., Guadagni F., Goldstein D., et al. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells. J. Clin. Oncol. 10:1992;735-746.
12. Greiner J.W., Ullmann C.D., Nieroda C., et al. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (I-131 CC-49) when given in combination with gamma-interferon. Cancer Res. 53:1993;600-608.
13. Guadagni F., Witt P.L., Robbins P.F., et al. Regulation of carcinoembryonic antigen expression in different human colorectal tumour cells by interferon-gamma. Cancer Res. 50:1990;6248-6255.
14. Kantor J., Tran R., Greiner J.W., et al. Modulation of carcinoembryonic antigen messenger RNA levels in human colorectal tumor cells by interferon-gamma. Cancer Res. 49:1989;2651-2655.
15. Lotz M. Interleukin-6. A comprehensive review. Cancer Treat. Res. 80:1995;209-233.
16. Reilly R.M., Sandhu J., Alvarez-Diez T.M., et al. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin. Pharmacokinet. 28(2):1995;126-142.
17. Roselli M., Guadagni F., Buonomo A., et al. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen. J. Clin. Oncol. 14(7):1996;2031-2042.
18. Rosenblum M.G., Lamki L.M., Murray J.L., et al. Interferon induced changes in pharmacokinetics and tumor uptake of indium-111 labeled antimelanoma antibody 96.5 in melanoma patients. J. Natl. Cancer Inst. 80:1988;160-165.